Alpha 2.0
Login Register
» Authors » M Buysschaert

M Buysschaert

Explore the profile of M Buysschaert including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 141
Citations 560
Followers 0
Related Specialties
Endocrinology
General Medicine
General Surgery
Top 10 Co-Authors
A E Lambert
J M Ketelslegers
M P Hermans
J Donckier
V Preumont
J Jamart
J E Donckier
L Lambotte
J Rahier
O Alexopoulou
Published In
Acta Clin Belg
Diabetes Metab
Diabete Metab
Diabetes Care
Diabet Med
Affiliations
Soon will be listed here.
Recent Articles
1.
Advances in cystic fibrosis-related diabetes: Current status and future directions
Lurquin F, Buysschaert M, Preumont V
Diabetes Metab Syndr . 2023 Nov; 17(11):102899. PMID: 37939435
Aims: The aim of this review is to give an update of the recent advances in the pathophysiology, prognosis, diagnosis and treatments of cystic fibrosis-related diabetes (CFRD). Methods: The literature...
2.
1-h post-load plasma glucose for detecting early stages of prediabetes
Buysschaert M, Bergman M, Valensi P
Diabetes Metab . 2022 Oct; 48(6):101395. PMID: 36184047
Prediabetes is a very prevalent condition associated with an increased risk of developing diabetes and/or other chronic complications, in particular cardiovascular disorders. Early detection is therefore mandatory since therapeutic interventions...
3.
Impact of flash glucose monitoring on glycaemic control and quality of life in patients with type 1 diabetes: A 18-month follow-up in real life
Rouhard S, Buysschaert M, Alexopoulou O, Preumont V
Diabetes Metab Syndr . 2020 Jan; 14(2):65-69. PMID: 31991294
We conducted a prospective observational study to evaluate the medium-term impact of the flash glucose monitoring system (FGM) in a type 1 diabetic population. We included 248 patients, switched from...
4.
Current status of insulin degludec in type 1 and type 2 diabetes based on randomized and observational trials
Preumont V, Buysschaert M
Diabetes Metab . 2019 May; 46(2):83-88. PMID: 31055056
Insulin degludec is a new ultra-long-action basal insulin. Using treat-to-target protocols, controlled trials have shown comparable HbA reductions with insulin degludec and comparators in both type 1 and type 2...
5.
Long-term effects of GLP-1 receptor agonists in type 2 diabetic patients: A retrospective real-life study in 131 patients
Hemmer A, Maiter D, Buysschaert M, Preumont V
Diabetes Metab Syndr . 2019 Jan; 13(1):332-336. PMID: 30641721
Aim: We evaluate retrospectively long-term effects of GLP-1 receptor agonists in type 2 diabetic patients treated between 2008 and 2016. Methods: 131 patients treated by GLP-1 receptor agonists (GLP-1RAs) were...
6.
Dental caries and diabetes: A Belgian survey of patients with type 1 and type 2 diabetes
Buysschaert M, Buysschaert B, Jamart J
Diabetes Metab . 2018 Jun; 46(3):248-249. PMID: 29934226
No abstract available.
7.
Gestational diabetes mellitus screening according to Carpenter-Coustan and IADPSG criteria: A 7-year follow-up of prevalence, treatment and neonatal complications at a Belgian general hospital
Oriot P, Radikov J, Gilleman U, Loumaye R, Ryckoort V, Debue E, et al.
Diabetes Metab . 2017 Oct; 44(3):309-312. PMID: 29066156
No abstract available.
8.
Oral hygiene behaviours and tooth-loss assessment in patients with diabetes: A report from a diabetology centre in Belgium
Buysschaert M, Tshongo Muhindo C, Alexopoulou O, Rahelic D, Reychler H, Preumont V
Diabetes Metab . 2016 Oct; 43(3):272-274. PMID: 27692742
No abstract available.
9.
Predicting factors of hypoglycaemia in elderly type 2 diabetes patients: Contributions of the GERODIAB study
Bordier L, Buysschaert M, Bauduceau B, Doucet J, Verny C, Lassmann Vague V, et al.
Diabetes Metab . 2015 Apr; 41(4):301-303. PMID: 25845279
The burden of hypoglycaemia is important, particularly in elderly type 2 diabetes (T2D) patients. Unfortunately, however, few studies are available concerning this population. GERODIAB is a prospective, multicentre, observational study...
10.
Improvement of psoriasis during glucagon-like peptide-1 analogue therapy in type 2 diabetes is associated with decreasing dermal γδ T-cell number: a prospective case-series study
Buysschaert M, Baeck M, Preumont V, Marot L, Hendrickx E, Van Belle A, et al.
Br J Dermatol . 2014 Feb; 171(1):155-61. PMID: 24506139
Background: A few case reports suggest that incretin-based therapies could improve psoriasis in patients with type 2 diabetes, the mechanism(s) of which remain unclear. Objectives: To determine the effects after...